353 related articles for article (PubMed ID: 16503143)
21. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH
J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880
[TBL] [Abstract][Full Text] [Related]
22. The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity.
Pérez-García X; Rumbo A; Larriba MJ; Ordóñez P; Muñoz A; Mouriño A
Org Lett; 2003 Oct; 5(22):4033-6. PubMed ID: 14572242
[TBL] [Abstract][Full Text] [Related]
23. Characterization of five 19-nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties.
Olivera CJ; Bula CM; Bishop JE; Adorini L; Manchand P; Uskokovic MR; Norman AW
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):99-106. PubMed ID: 15225754
[TBL] [Abstract][Full Text] [Related]
24. 13,13-Dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D₃ (2MD): total synthesis, docking to the VDR, and biological evaluation.
Plonska-Ocypa K; Sibilska I; Sicinski RR; Sicinska W; Plum LA; DeLuca HF
Bioorg Med Chem; 2011 Dec; 19(23):7205-20. PubMed ID: 22018918
[TBL] [Abstract][Full Text] [Related]
25. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
[TBL] [Abstract][Full Text] [Related]
26. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
27. New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations.
Vanhooke JL; Tadi BP; Benning MM; Plum LA; DeLuca HF
Arch Biochem Biophys; 2007 Apr; 460(2):161-5. PubMed ID: 17227670
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of 2α- and 2β-(3-hydroxypropyl)- 7,8-cis-14-epi-1α,25-dihydroxy-19-norvitamin D
Sawada D; Ochiai E; Takeuchi A; Kakuda S; Kamimura-Takimoto M; Kawagoe F; Kittaka A
J Steroid Biochem Mol Biol; 2017 Oct; 173():79-82. PubMed ID: 27629592
[TBL] [Abstract][Full Text] [Related]
29. New C15-substituted active vitamin D3.
Shindo K; Kumagai G; Takano M; Sawada D; Saito N; Saito H; Kakuda S; Takagi K; Ochiai E; Horie K; Takimoto-Kamimura M; Ishizuka S; Takenouchi K; Kittaka A
Org Lett; 2011 Jun; 13(11):2852-5. PubMed ID: 21539305
[TBL] [Abstract][Full Text] [Related]
30. Identification of a highly potent vitamin D receptor antagonist: (25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3 (ADMI3).
Igarashi M; Yoshimoto N; Yamamoto K; Shimizu M; Ishizawa M; Makishima M; DeLuca HF; Yamada S
Arch Biochem Biophys; 2007 Apr; 460(2):240-53. PubMed ID: 17214957
[TBL] [Abstract][Full Text] [Related]
31. 2-(3'-Hydroxypropylidene)-1alpha-hydroxy-19-norvitamin D compounds with truncated side chains.
Glebocka A; Sicinski RR; Plum LA; DeLuca HF
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):310-5. PubMed ID: 17223340
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, metabolism, and biological activity of 2-[3-(tetrazolyl)propyl]-1α,25-dihydroxy-19-norvitamin D
Takano M; Yasuda K; Higuchi E; Tohyama E; Takeuchi A; Sakaki T; Kittaka A
J Steroid Biochem Mol Biol; 2016 Nov; 164():40-44. PubMed ID: 26232635
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues.
Demin S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
Bioorg Med Chem Lett; 2004 Aug; 14(15):3885-8. PubMed ID: 15225690
[TBL] [Abstract][Full Text] [Related]
34. New 1alpha,25-dihydroxy-19-norvitamin D(3) compounds constrained in a single A-ring conformation: synthesis of the analogues by ring-closing metathesis route and their biological evaluation.
Glebocka A; Sokolowska K; Sicinski RR; Plum LA; Deluca HF
J Med Chem; 2009 Jun; 52(11):3496-504. PubMed ID: 19402630
[TBL] [Abstract][Full Text] [Related]
35. New 1alpha,25-dihydroxy-19-norvitamin D3 analogs with a frozen A-ring conformation.
Glebocka A; Sicinski RR; Plum LA; DeLuca HF
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):46-50. PubMed ID: 20214980
[TBL] [Abstract][Full Text] [Related]
36. Conformation-function relationship of vitamin D: conformational analysis predicts potential side-chain structure.
Yamada S; Yamamoto K; Masuno H; Ohta M
J Med Chem; 1998 Apr; 41(9):1467-75. PubMed ID: 9554880
[TBL] [Abstract][Full Text] [Related]
37. Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones.
Saito N; Matsunaga T; Saito H; Anzai M; Takenouchi K; Miura D; Namekawa J; Ishizuka S; Kittaka A
J Med Chem; 2006 Nov; 49(24):7063-75. PubMed ID: 17125259
[TBL] [Abstract][Full Text] [Related]
38. Highly potent 2-methylene analogs of 1α,25-dihydroxyvitamin D3: synthesis and biological evaluation.
Sibilska IK; Szybinski M; Sicinski RR; Plum LA; Deluca HF
J Steroid Biochem Mol Biol; 2013 Jul; 136():9-13. PubMed ID: 23410597
[TBL] [Abstract][Full Text] [Related]
39. Two-dimensional alanine scanning mutational analysis of the interaction between the vitamin D receptor and its ligands: studies of A-ring modified 19-norvitamin D analogs.
Shimizu M; Yamamoto K; Mihori M; Iwasaki Y; Morizono D; Yamada S
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):75-81. PubMed ID: 15225750
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, structure, and biological activity of des-side chain analogues of 1α,25-dihydroxyvitamin D3 with substituents at C18.
Verlinden L; Verstuyf A; Eelen G; Bouillon R; Ordóñez-Morán P; Larriba MJ; Muñoz A; Rochel N; Sato Y; Moras D; Maestro M; Seoane S; Dominguez F; Eduardo-Canosa S; Nicoletti D; Moman E; Mouriño A
ChemMedChem; 2011 May; 6(5):788-93. PubMed ID: 21520419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
